使用人性化小鼠识别有效的CCR2抑制剂用于癌症治疗

Shigeaki Sugiyama1, Kanae Yumimoto1, Shun Fujinuma1

  • 1Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.

Journal of biochemistry
|November 10, 2023
PubMed
概括

MK0812是最有效的C-C化学因子受体2型 (CCR2) 抑制剂,在人性化小鼠模型中显著减少乳腺癌肺转移. 这项研究强调MK0812是CCR2相关疾病的有前途的治疗候选者.